BETR — BetterLife Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- CA$9.87m
- CA$13.80m
Annual cashflow statement for BetterLife Pharma, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -36.4 | -12.2 | -9.37 | -2.9 | -3.62 |
| Depreciation | |||||
| Non-Cash Items | 30.4 | 2.42 | 4.26 | 0.104 | 0.847 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.54 | -1.48 | 3.59 | 0.322 | 0.753 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -7.16 | -11.2 | -1.5 | -2.47 | -2.02 |
| Capital Expenditures | -0.097 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.025 | 0 | — | — | — |
| Sale of Business | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.072 | 0 | — | — | — |
| Financing Cash Flow Items | — | -0.077 | 0.503 | 0 | 0.063 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.09 | 11.2 | 1.34 | 2.5 | 1.99 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.13 | 0.019 | -0.165 | 0.029 | -0.029 |